Drug Shortage Report for MAXIDEX
| Report ID | 97281 |
| Drug Identification Number | 00042560 |
| Brand name | MAXIDEX |
| Common or Proper name | MAXIDEX 0.1% SUSP 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE |
| Strength(s) | 0.1% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2019-10-23 |
| Estimated end date | 2020-02-28 |
| Actual end date | 2020-02-26 |
| Shortage status | Resolved |
| Updated date | 2020-02-27 |
| Company comments | Supply interruption |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2020-02-27 | English | Compare |
| v16 | 2020-02-26 | French | Compare |
| v15 | 2020-02-26 | English | Compare |
| v14 | 2020-02-24 | French | Compare |
| v13 | 2020-02-24 | English | Compare |
| v12 | 2019-12-16 | French | Compare |
| v11 | 2019-12-16 | English | Compare |
| v10 | 2019-12-16 | French | Compare |
| v9 | 2019-12-16 | English | Compare |
| v8 | 2019-12-02 | French | Compare |
| v7 | 2019-12-02 | English | Compare |
| v6 | 2019-10-25 | French | Compare |
| v5 | 2019-10-25 | English | Compare |
| v4 | 2019-10-25 | French | Compare |
| v3 | 2019-10-25 | French | Compare |
| v2 | 2019-10-25 | English | Compare |
| v1 | 2019-10-25 | English | Compare |
Showing 1 to 17 of 17